Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 4257 citing articles:

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle, Alejandro Forner, Josep M. Llovet, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 1, pp. 182-236
Closed Access | Times Cited: 10058
Hepatocellular carcinoma
Alejandro Forner, María Reig, Jordi Bruix
The Lancet (2018) Vol. 391, Iss. 10127, pp. 1301-1314
Closed Access | Times Cited: 4603
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair M. Younossi, Quentin M. Anstee, M. Marietti, et al.
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 15, Iss. 1, pp. 11-20
Closed Access | Times Cited: 4460
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 1, pp. 202-209
Open Access | Times Cited: 3253
Burden of liver diseases in the world
Sumeet K. Asrani, Harshad Devarbhavi, John E. Eaton, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 1, pp. 151-171
Closed Access | Times Cited: 3038
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata, Ann‐Lii Cheng, Norihiro Kokudo, et al.
Hepatology International (2017) Vol. 11, Iss. 4, pp. 317-370
Open Access | Times Cited: 1886
Non-alcoholic fatty liver disease
Elizabeth E. Powell, Vincent Wai‐Sun Wong, Mary E. Rinella
The Lancet (2021) Vol. 397, Iss. 10290, pp. 2212-2224
Closed Access | Times Cited: 1843
Non-alcoholic fatty liver disease – A global public health perspective
Zobair M. Younossi
Journal of Hepatology (2018) Vol. 70, Iss. 3, pp. 531-544
Open Access | Times Cited: 1792
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang, Hashem B. El‐Serag, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 4, pp. 223-238
Open Access | Times Cited: 1328
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 12, pp. 1113-1124
Open Access | Times Cited: 1321
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castéra, Mireen Friedrich‐Rust, Rohit Loomba
Gastroenterology (2019) Vol. 156, Iss. 5, pp. 1264-1281.e4
Open Access | Times Cited: 1172
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1144
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
Annalisa Berzigotti, Emmanuel Tsochatzis, Jérôme Boursier, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 3, pp. 659-689
Open Access | Times Cited: 1144
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero‐Gómez, Shira Zelber‐Sagi, Michael I. Trenell
Journal of Hepatology (2017) Vol. 67, Iss. 4, pp. 829-846
Open Access | Times Cited: 1097
COVID-19: Abnormal liver function tests
Qingxian Cai, Deliang Huang, Hong Yu, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 566-574
Open Access | Times Cited: 1037
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
Leon A. Adams, Quentin M. Anstee, Herbert Tilg, et al.
Gut (2017) Vol. 66, Iss. 6, pp. 1138-1153
Open Access | Times Cited: 990
New trends on obesity and NAFLD in Asia
Jian-Gao Fan, Seung Up Kim, Vincent Wai‐Sun Wong
Journal of Hepatology (2017) Vol. 67, Iss. 4, pp. 862-873
Open Access | Times Cited: 976
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas, David Petroff, M. Sasso, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 5, pp. 1022-1030
Closed Access | Times Cited: 953
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Pοlyzos, Јannis Kountouras, Christos S. Mantzoros
Metabolism (2018) Vol. 92, pp. 82-97
Closed Access | Times Cited: 947
NAFLD and diabetes mellitus
Herbert Tilg, Alexander R. Moschen, Michael Roden
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 14, Iss. 1, pp. 32-42
Closed Access | Times Cited: 846
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 774
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 732
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict, Xuchen Zhang
World Journal of Hepatology (2017) Vol. 9, Iss. 16, pp. 715-715
Open Access | Times Cited: 692
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Vincent Wai‐Sun Wong, et al.
Gastroenterology (2018) Vol. 155, Iss. 2, pp. 443-457.e17
Open Access | Times Cited: 672
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 651
Page 1 - Next Page

Scroll to top